Abstract

Discogenic back pain is multifactorial; hence, physicians often struggle to identify the underlying source of the pain. As a result, discogenic back pain is often hard to treat—even more so when clinical treatment strategies are of questionable efficacy. Based on a broad literature review, our aim was to define discogenic back pain into a series of more specific and interacting pathologies, and to highlight the need to develop novel approaches and treatment strategies for this challenging and unmet clinical need. Discogenic pain involves degenerative changes of the intervertebral disc, including structural defects that result in biomechanical instability and inflammation. These degenerative changes in intervertebral discs closely intersect with the peripheral and central nervous systems to cause nerve sensitization and ingrowth; eventually central sensitization results in a chronic pain condition. Existing imaging modalities are nonspecific to pain symptoms, whereas discography methods that are more specific have known comorbidities based on intervertebral disc puncture and injection. As a result, alternative noninvasive and specific diagnostic methods are needed to better diagnose and identify specific conditions and sources of pain that can be more directly treated. Currently, there are many treatments/interventions for discogenic back pain. Nevertheless, many surgical approaches for discogenic pain have limited efficacy, thus accentuating the need for the development of novel treatments. Regenerative therapies, such as biologics, cell‐based therapy, intervertebral disc repair, and gene‐based therapy, offer the most promise and have many advantages over current therapies. © 2019 The Authors. JBMR Plus Published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research

Highlights

  • Low back pain (LBP) is one of the major clinical and socioeconomic global health burdens

  • Axial back pain is multifactorial without a clear source of pain, which can arise from the Intervertebral disc (IVD) and associated structures of the motion segment, such as facet joints, ligaments, and spinal muscles.[9,10,11,12,13,14] Axial LBP that is thought to originate from disc degeneration remains hard to define, diagnose, and treat

  • Discogenic pain involves multifactorial changes occurring with late IVD degeneration that interact with the peripheral nervous system and the central nervous system (CNS) to induce pain (Fig. 2)

Read more

Summary

Introduction

Low back pain (LBP) is one of the major clinical and socioeconomic global health burdens. Axial back pain is multifactorial without a clear source of pain, which can arise from the IVDs and associated structures of the motion segment, such as facet joints, ligaments, and spinal muscles.[9,10,11,12,13,14] Axial LBP that is thought to originate from disc degeneration (discogenic pain) remains hard to define, diagnose, and treat It commonly requires prolonged treatment, has mixed-to-poor surgical outcomes, and opioids are often prescribed.[15] Many studies have demonstrated high sensitivity of pain to IVD pathologies on MRI including highintensity zones and Modic changes,(16,17) this sensitivity is often not specific to pain presentation. This lack of a uniform definition lies in part because IVD degeneration is hard to isolate and is commonly implicated in pathologies in adjacent spinal structures, making improved nomenclature and consensus on spine pathology definitions and diagnosis an important ongoing area for research.[19,20] Our aims here are [1] to review the available definitions of discogenic back pain, [2] to describe the diagnostic criteria for discogenic back pain, [3] to examine current treatments for discogenic back pain, and [4] to identify sources of discogenic back pain to provide potential research targets for future treatments

Objectives
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call